Pages that link to "Q50461771"
Jump to navigation
Jump to search
The following pages link to Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study (Q50461771):
Displaying 6 items.
- Candidate biomarkers in heart failure with reduced and preserved ejection fraction (Q38572500) (← links)
- Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. (Q39014581) (← links)
- The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock. (Q51359233) (← links)
- Novel Biomarkers to Detect Target Organ Damage in Acute Hypertension (Q51738029) (← links)
- Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study (Q59796342) (← links)
- UMBRELLA protocol: systematic reviews of multivariable biomarker prognostic models developed to predict clinical outcomes in patients with heart failure (Q99631124) (← links)